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display retarded FITC-BSA release in both initial and late stages compared to release from the PLGA 
microspheres or alginate fibre alone. In addition, incorporation of higher concentrations of protein-loaded 
PLGA microspheres increased protein release compared to the fibres with lower concentrations of BSA-
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Alginate has been a biologically viable option for controlled local delivery of bioactive 
molecules in vitro and in vivo. Specific bioactive molecule release profiles are achieved often 
by controlling polymer composition/concentration, which also determines the modulus of 
hydrogel. This largely limits alginate-mediated bioactive molecule delivery to single-factors of 
uniform concentration applications, rather than applications that may require (multiple) 
bioactive molecules delivered at a concentration gradient for chemotactic purposes. Here we 
report a two-phase PLGA/alginate delivery system composed of protein-laden poly D, L-lactic-
co-glycolic acid (PLGA) microspheres wet-spun into alginate fibres. Fluorescein 
isothiocyanate-conjugated bovine serum albumin (FITC-BSA) was used as a model protein 
and the developed structures were characterized. The fabrication system devised was shown to 
produce wet-spun fibres with a protein concentration gradient (G-Alg/PLGA fibre). The two-
phase delivery matrices display retarded FITC-BSA release in both initial and late stages 
compared to release from the PLGA microspheres or alginate fibre alone. In addition, 
incorporation of higher concentrations of protein-loaded PLGA microspheres increased protein 
release compared to the fibres with lower concentrations of BSA-loaded microspheres. The 
“programmable” microspheres concentration gradient fibre methodology presented here may 
enable development of novel alginate scaffolds with the ability to guide tissue regeneration 
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Over the past two decades, localized delivery of therapeutic proteins such as protein drugs and 
growth factors to dysfunctional or damaged soft tissues has gained significant importance to a 
number of biomedical areas, particularly in tissue engineering applications.1 Localized delivery 
systems overcome the drawbacks associated with systematic approaches wherein distribution 
of therapeutic molecules via the circulatory system often results in diffuse efficacy and side-
effects in non-target tissues.2,3 Therefore, fabrication of effective and versatile protein delivery 
systems is important to most, if not all, bioactive molecule delivery, pharmaceutics, and tissue 
engineering applications.4,5 From this viewpoint, the general biocompatibility and hydrophilic 
nature of alginate (Alg) based structures has made Alg one of the most common platforms 
being investigated for therapeutic protein delivery.6-8  
 
A critical challenge in the field of bioactive molecules delivery in tissue engineering is to 
fabricate structures that deliver the appropriate bioactive molecule(s) for an extended period in 
a manner that effectively directs the regeneration of target tissue.9 Microencapsulation of 
protein within a biodegradable polymer has been recognized as an attractive way to control the 
sustained delivery of bioactive molecules.10,11 For instance, poly(D, L-lactic-co-glycolic acid) 
(PLGA) microspheres, because of their modestly-priced and reproducible fabrication 
processes, have been extensively studied for controlled sustained delivery of proteins.12-14 
PLGA microspheres’ long-term degradation can facilitate release of bioactive molecule up to 
several months.15,16 Further incorporating the bioactive molecule-loaded PLGA microspheres 
into a hydrogel structure has been shown to provide an added element of control to the release 
profile by mitigating the initial burst release that is often associated with the delivery either 




A number of structures have been fabricated and evaluated for their application in targeted 
local delivery of bioactive molecules for cell guidance through chemotaction.21-23 In these 
applications, biofactor gradients within the structures provide chemotactic cues for 
directionally-guided cell growth and/or migration. However, these structures required highly 
complex technologies for fabrication and very few were able to generate a non-burst release 
profile that: i) effectively controlled delivery concentrations to those target cells/tissues, and 
ii) did not deliver most of the bioactive molecules in a very short period.  
 
Fibrous structures have gained attention as bioactive molecule delivery systems. This is due to 
the simplicity of fabrication techniques as well as the large surface areas of the prepared fibres 
across which bioactive molecules are transported to the site of interest.24 Electrospinning and 
wet spinning have been intensively explored to produce fibrous structures.25-28 Wet-spinning 
is a non-solvent-induced phase inversion technique that is used to form continuous polymer 
microfibres by injecting the polymer solution into a coagulation bath composed of a poor 
solvent/solvent mixture with respect to the polymer. It has a potential advantage of converting 
biomaterials into fibres without the use of a high voltage, which may cause protein 
denaturation.29 Wet-spinning can also produce filaments into complex geometries to address 
the needs for different bioactive molecule delivery applications.30,31  
 
In this study, we present a simple and programmable approach for fabrication of Alg fibres 
containing protein-loaded microspheres. We incorporate the protein-loaded microspheres into 
the fibre structure to achieve sustained release of protein in a graduated manner conducive to 
chemotactic applications. This novel gradient fibre is specifically programmable in terms of 
the presence of bioactive molecules along the fibre length while also potentially providing a 





Poly(D, L-lactide-co-glycolic acid) (PLGA, 50:50, inherent viscosity 0.4 dL/g (25 °C, 0.5 g/dL 
in CHCl3)) was purchased from Corbion, Singapore. Alginic acid sodium salt from brown algae 
(Alg) (viscosity: 4-12 cP, 1 % in H2O 25 °C), poly (vinyl alcohol) (PVA) (Mw 50,000–85,000 
Da, 96% hydrolyzed), calcium chloride dihydrate, ethylenediaminetetraacetic acid (EDTA), 
sodium citrate and fluorescein isothiocyanate-conjugated bovine serum albumin (FITC-BSA) 
were all purchased from Sigma-Aldrich, Australia. Analytical grade dichloromethane (DCM) 
was obtained from Chem-Supply Pty Ltd, Australia. Milli-Q water (18 MΩ cm−1) was used in 
the preparation of aqueous solutions. A simulated body fluid (SBF) solution, with ion 
concentrations equal to those of human blood plasma and primed with the following ion 
concentrations of 142 mM Na+, 5 mM K+, 1.5 mM Mg2+, 2.5 mM Ca2+, 103 mM Cl−, 27 mM 
HCO3
−, 1.0 mM HPO4
2− and 0.5 mM SO4
2− and with a pH adjusted to 7.4,32 was used as the 
medium for the protein release study. EASYstrainerTM with a mesh size of 70 µm and Millex® 
Syringe sterile filters (pore size = 0.22 µm) were obtained from Greiner Bio-One (Austria) and 
MERCK (Germany), respectively. 
 
Preparation of the protein-loaded PLGA microspheres  
The PLGA microspheres were prepared via a modified water/oil/water (W/O/W) double-
emulsion method. 1 g of PLGA was dissolved in 5 mL of DCM to form an oil phase (O). FITC-
BSA, chosen as the model protein, was dissolved in Milli-Q water at 50 mg/ml concentration 
to obtain an inner aqueous phase (W1). The W1 was dispersed into an O phase by sonication 
(112 W, 5 min). The resulting primary emulsion (W1/O) was poured into 10 ml of 4% w/v 
aqueous PVA solution (as the outer aqueous phase (W2)) under sonication (112 W, 2 min). 
The whole suspension was then added to 250 ml of aqueous 0.4% w/v PVA solution and the 
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resulting double-emulsion was stirred at 1500 rpm for 2 h to evaporate the organic solvent. The 
PLGA microspheres were collected by centrifugation and washed with Milli-Q water three 
times. The final suspension of FITC-BSA-loaded PLGA microspheres in water was filtered 
using an EASYstrainerTM with a mesh size of 70 µm. The microspheres were then freeze-dried 
and stored at -20 °C.  
 
Wet spinning set-up and fabrication of Alg fibres with programmable loading of the 
protein-loaded PLGA microspheres  
A customised spinning setup was developed involving two spinning dopes (Fig. 1). Spinning 
dope A, denoted as Alg spinning dope, was composed of 4%w/v Alg in water, and spinning 
dope B, denoted as Alg/PLGA spinning dope, was prepared by mixing 4% w/v Alg with the 
FITC-BSA-loaded PLGA microspheres at a weight ratio of Alg/PLGA = 3/2. The mixing 
procedure involved magnetic stirring of the Alg/PLGA spinning suspension for 5 min followed 
by ultrasonication for 2 min. The two spinning dopes were extruded via syringe A and B 
respectively, with the extrusion rates being controlled using a CM Printing System-LinuxCNC 
via a home-designed coded software. The two spinning dopes were mixed together in a mixing 
tube C (with the length of 39 mm and interior diameter of 3.5 mm) where a home-designed 
interior blender (with a diameter of 3.2 mm) was housed to facilitate the mixing of the two 
spinning dopes. The resultant final spinning dope was then injected into a coagulation bath 
containing an aqueous CaCl2 solution (4% w/v). The coagulation bath was programmed to 
move at a predetermined speed of 50 cm.min-1 in parallel to the direction of spinning to avoid 
any stress to the as-spun fibre.  
 
To minimize the dead volume and waste of protein-loaded PLGA microspheres, the mixing 
tube C was prefilled with Alg spinning dope prior to the spinning process. Thus the as-spun 
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fibre contained an initial Alg-only part. The length of the Alg-only part can be calculated based 
on the extrusion rate of final spinning dope and the volume of the mixing tube C. At the 
completion of the spinning process, the initial Alg part was removed (at the cutting point shown 
in Fig. 1) to produce the desired fibre. 
 
In this study, two types of microsphere-loaded Alg fibres were fabricated and characterized: 
Alg fibre with uniform distribution of the protein-loaded PLGA microspheres (U-Alg/PLGA 
fibre), and Alg fibre with a concentration gradient of protein-loaded PLGA microspheres (G-
Alg/PLGA fibre). U-Alg/PLGA fibres were prepared by control of the extrusion rate ratio of 
the two spinning dopes, Alg spinning dope:Alg/PLGA spinning dope, at 1:1, using the 
procedure described above. Both Alg and Alg/PLGA spinning dopes were extruded at a fixed 
rate of 24 ml/h and mixed together to form the final spinning dope that was then extruded into 
the coagulation bath at a rate of 48 ml/h.  
 
The G-Alg/PLGA fibres were produced using a similar procedure, but the ratio of extrusion 
rate of Alg spinning dope and Alg/PLGA spinning dope was programmed to vary linearly from 
1:0 to 0:1 over a period of 15s. That is, the spinning procedure begun with an extrusion rate of 
48 ml/h for Alg spinning dope, and 0 ml/h for Alg/PLGA spinning dope, and ended with an 
extrusion rate of 0 ml/h for Alg spinning dope and 48 ml/h for Alg/PLGA spinning dope. 
During the spinning process, the extrusion rate of the final spinning dope was fixed at 48 ml/h. 
By controlling the extrusion rate ratio of the two spinning dopes, a programmable loading of 
the protein-loaded PLGA microspheres in Alg fibres can be readily achieved. 
 
For comparison, FITC-BSA-loaded Alg fibre (i.e. without prior encapsulation with PLGA) was 
also prepared using the same procedure as for U-Alg/PLGA fibres. To do so, spinning dope A 
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contained aqueous 4% w/v Alg solution and spinning dope B contained FITC-BSA dissolved 
in Alg solution 4% w/v (FITC-BSA/Alg, w/w, 1/90). 
 
Rheological characterisation of the Alg spinning dopes 
The rheological behaviour of the wet-spinning solutions was analysed using an AR-G2 
rheometer (TA Instruments, New Castle, DE) equipped with a Peltier plate thermal controller. 
A 2º/36mm cone and plate geometry was used in all measurements. The solutions were held at 
25 °C for 1 min prior to performing the experiments. Viscosity and shear stress were measured 
as a function of shear rate at 25 °C.  
 
Morphological characterisation 
Images of the as-spun and dried fibres were recorded by optical microscopy (Leica M205A, 
Austria). For scanning electron microscopy, the protein-loaded microspheres were mounted on 
metal stubs using conductive double-sided carbon tape and sputter-coated with a thin layer of 
gold (thickness = 15 nm). Microspheres diameters were analysed using Image J (n = 150). For 
longitudinal and cross-sectional imaging five sections of the hydrated G-Alg/PLGA fibre (at 
specific distances) were cut and inserted into pre-drilled holes (1 or 1.5 mm diameter) in a brass 
mounting block. The holes were of a depth which allowed fibres to be inserted upright and 
protrude from the surface. The block containing the mounted fibres was then plunged into 
liquid nitrogen for approximately 45 s and then the fibres were fractured using a liquid nitrogen 
cooled razor blade. The block was then quickly transferred to a LVSEM (JEOL JSM-6490 LV, 
Japan) for examination. Sample morphologies were then observed in secondary electron 




To confirm the presence and distribution of protein-loaded microspheres in the wet-spun fibres, 
the hydrated fibres were examined on a laser confocal scanning microscope (LCSM, Leica 
TCS SP2, Australia). The excitation and emission wavelengths used were 488 nm and 520 nm, 
respectively. Blank non-loaded Alg fibres were used as a negative control: firstly, to adjust all 
the parameters including the laser intensity and gain, until fluorescent signals could not be seen 
from the Alg fibre sample; then, without changing any settings, the same parameters were used 
to observe the fibres containing fluorescently labelled protein-loaded PLGA microspheres. 
 
Fourier Transform Infrared Spectroscopy (FT-IR) and mechanical characterisation of 
the as-prepared fibres 
The U-Alg/PLGA and G-Alg/PLGA fibres (air-dried at 20 ºC) were characterized using an FT-
IR spectrometer. The surface spectra were studied using an infrared microscope (AIM-8800, 
Shimadzu, Japan) in a reflectance mode equipped with a MCT (Mercury-Cadmium-Telluride) 
detector connected to the FT-IR instrument.  
 
Tensile tests were carried out on a dynamic mechanical tester (EZ-L Tester from Shimadzu, 
Japan) at a strain rate of 0.1 cm.min-1 and a gauge length of 30 mm (n = 3). The tensile strength 
was calculated according to the formula, α= F/A, where F is the maximum force (N) and A is 
the cross-sectional area (m2) of the fibre, which is considered as the maximum stress in stress-
strain curve of the fibres.33 Moreover, elastic modulus of U-Alg/PLGA or G-Alg/PLGA fibres 
is defined as the ratio of tensile stress to tensile strain in the elastic part of the respective stress-
strain curve. 
 
Quantification of protein loading 
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For FITC-BSA-loaded PLGA microspheres, the microspheres (10 ∼ 15 mg) were weighed and 
dissolved in 0.5 ml DCM and then 0.5 ml Milli-Q water was added. After vigorous agitation, 
the suspension was centrifuged (3000 rpm, 5 min) and a 200 µl sample from the aqueous phase 
was extracted for further analysis using a microplate reader at Exmax = 485 nm and 
Emmax = 520 nm (the excitation and emission wavelengths, respectively). The protein loading 
(µg/mg microspheres) was quantified using a standard curve of fluorescence intensity vs FITC-
BSA concentration. The results were expressed as mean ± standard deviation (n = 3). 
 
For U-Alg/PLGA fibres, the fibres (length = 3 cm, n = 7) were weighed and dissolved in an 
aqueous solution containing EDTA (50 mM) and sodium citrate (100 mM).8,34 After filtering 
the suspension, the remaining microspheres were washed with water to remove residual salt, 
dried at 37 °C and weighed. The result was expressed as mean ± standard deviation (n = 7). 
Based on the protein loading of the PLGA microspheres and mass of PLGA microspheres 
present in each fibre, the amount of protein loading in each fibre was calculated.   
 
For G-Alg/PLGA fibres, the total protein loading in the fibres (length = 3 cm, n = 7) was 
determined using the same procedure as for U-Alg/PLGA fibres. In addition, to characterise 
the protein concentration gradient structure, the G-Alg/PLGA fibres (n = 7) were cut into half. 
Both the low protein-loading end and high protein-loading end were characterised for protein 
loading using the above method.  
 
Protein Release Studies 
Protein release studies from FITC-BSA-loaded PLGA microspheres, or Alg fibres with or 
without FITC-BSA-loaded PLGA microspheres were performed in SBF at 37 °C, with 
unloaded PLGA microspheres used as controls. Briefly, each sample was weighed and then 
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placed in 1.5 ml Eppendorf tubes with 300 µl of SBF and placed in an incubator shaker under 
slow shaking conditions. At each time point (0, 1, 3, 5, 7, 10, 14, 21, 28 and 35 days) the SBF 
supernatant was removed and replaced with fresh SBF and re-incubated until the next 
designated sampling time point. The released samples were stored at -20 °C and the protein 
content of the samples were quantified using a fluorescence microplate reader at 
Exmax = 485 nm and Emmax = 520 nm (n = 3). 
 
The premature protein release (i.e. protein released from the FITC-BSA-loaded microspheres 
during the mixing with the alginate prior to wet-spinning) was assessed. To do so, a mock wet-
spinning process was followed (i.e. the extruded material did not interact with the coagulation 
bath). Briefly, 1 ml of alginate dope containing the FITC-BSA-loaded microspheres was 
extruded from the needle and collected. The sample was diluted 10 times, centrifuged and 
syringe filtered (pore size 0.22 µm). The filtered solution was again diluted 10 times and then 
assessed for protein content. 
 
For G-Alg/PLGA fibres, in addition to monitoring the protein release as a function of time, the 
influence of the protein concentration gradient structure (Fig. 1c) on protein release was also 
assessed. The G-Alg/PLGA fibres (n = 7) were cut in half and both the low protein-loading end 
and high-protein loading ends were monitored for protein release as a function of time, using 
the same protocol as described for the FITC-BSA-loaded PLGA microspheres. 
 
Results and Discussion 
Preparation and characterisation of microspheres 
The LVSEM image of the freeze-dried FITC-BSA-loaded PLGA microspheres and the 
confocal scanning microscopy image of the microspheres suspended in Alg spinning dope are 
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shown in Fig. 2. The microspheres prepared in this study exhibit smooth surfaces (Fig. 2a). 
The diameter of the microspheres ranged from 3 to 84 µm, with a mean size of ~ 25.8 µm. Fig. 
2b shows that the FITC-BSA-loaded PLGA microspheres were well dispersed in the Alg 
spinning dope, with no observable agglomeration. Fig. 2c shows the size distribution of the 
protein-loaded PLGA microspheres. The encapsulation efficiency of FITC-BSA into the 
PLGA microspheres was ~ 61.0 ± 8.9%.  
 
Rheological characterisation of the Alg spinning dopes 
The study of the rheological behaviour of spinning dopes is critical for production of a wet-
spun product. For co-spinning of multiple-component dopes, matching the rheology of the 
components is also important; any non-compliance in rheology of the two dopes will result in 
poor mixing of spinning dopes, and subsequently, formation of inhomogeneous final spinning 
dope that leads to poor quality wet-spun fibres.  
 
Under shear, Alg polymer chains are in a less expanded conformation and become less 
entangled causing their viscosity to fall. Fig. 3a and 3b show the variations in viscosity and 
shear stress for Alg and Alg/PLGA spinning dopes as a function of shear rate, respectively. To 
extrude the Alg spinning dopes through a needle/spinneret to form microfibres, the viscosity 
of the dope should be typically in the range of 0.01-2 Pa.s versus the shear rate range of 1-100 
1/s.35,36 The presence of PLGA microspheres caused slight variations (≤ 0.4 Pa.s) in the 
rheological behaviour of Alg/PLGA spinning dope but both dopes remained fairly constant as 
the shear rate increased. Considering the relatively similar rheological behaviour of these two 
spinning dopes (under the supposed shear rate range for wet-spinning), it is expected that they 




Morphological characterisation of the as-prepared fibres 
Visual inspection of the U-Alg/PLGA fibres showed a smooth surface morphology and that 
FITC-BSA-loaded microspheres are uniformly distributed inside the fibres (Fig. 4a and 4b). 
This structure could be attributed to the difference between the interior diameter of the mixing 
tube C (d = 3.5 mm) and the blender’s diameter (d = 3.2 mm) (Fig. 1b). As previously 
mentioned, prior to the spinning process, the mixing tube was initially filled with the Alg 
spinning dope, and through the spinning process, the blender mixed the two extruded spinning 
dopes in the middle of the tube. This can produce a final spinning dope bearing an outer thin 
layer of Alg, which then resulted in wet-spun fibres with an Alg coating. This view is supported 
by our FT-IR spectroscopy characterisation which is discussed in the next section. 
 
We studied the morphology of G-Alg/PLGA fibres to investigate the gradient structure. Fig. 
5a shows the longitudinal LVSEM image of a hydrated G-Alg/PLGA fibre at the high protein-
loading end, and Fig. 5b and 5c show the schematic and the longitudinal optical image of G-
Alg/PLGA fibre, respectively. The G-Alg/PLGA fibre, like U-Alg/PLGA fibres, has a 
relatively smooth surface morphology even in the region with the highest concentration of 
microspheres (Fig. 5a inset). This microsphere concentration gradient structure of the G-
Alg/PLGA fibre can be observed in Fig. 5c. Fig. 5i-5v represent the cross-sectional LVSEM 
images of hydrated G-Alg/PLGA fibre at 5 different points (specified in Fig. 5c). Fig. 5iv-a is 
a closer view of the central part of Fig. 5iv. These images present the distribution of 
microspheres inside the fibre structure. The laser confocal scanning image of G-Alg/PLGA 
fibre shows the gradient distribution of the fluorescently labelled microspheres (green, Fig. 5d), 
which is characterised by the intensity mapping of the green fluorescence that increases 
progressively from the right-hand end (low concentration of microspheres) to the left-hand end 
of the fibre (high concentration of microspheres). On closer observation (Fig. 5d-a, 5d-b, 5d-c 
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and 5d-d), it is evident that the number of microspheres in the four insets increases from right 
to left. 
           
Fourier Transform Infrared Spectroscopy (FT-IR) and mechanical characterisation of 
the as-prepared fibres 
For G-Alg/PLGA fibres, FT-IR spectra were recorded at five distinct sections from the low 
protein concentration end to the high protein concentration end. Our results showed no 
discernible difference in the spectra gathered at these positions (data not shown). Furthermore, 
both U-Alg/PLGA and G-Alg/PLGA fibres showed almost similar spectra as those of pure 
alginate, indicating the presence of alginate structure at the fibre surface (Fig. 6). The major 
peaks in the characteristic spectra of alginate can be observed at 2924 cm−1 and 1405 cm−1 due 
to stretching –CH2 and the carboxylic groups, respectively. Moreover, the peak at 1594 cm
−1 
indicates the asymmetric stretch of C–O–H. Other main peaks attributed to the Alg are seen at 
3311 cm−1 and 1120 cm−1, corresponding to the stretching vibration of O–H and stretching 
vibration of secondary alcohol (CH–OH), respectively.37-38 Minor peaks at 1754 cm−1 and 1161 
cm−1 were noted in both spectra, which are associated with the carbonyl bond C=O stretching 
vibration and the C–O stretching, respectively, both of which are characteristic of PLGA.39,40   
 
The mechanical properties of the U-Alg/PLGA and G-Alg/PLGA fibres were investigated to 
assess the effect of the distribution gradient of the FITC-BSA-loaded PLGA spheres on the 
final properties of these fibres. All the fibres were cut into 3 cm long pieces for this testing. 
Fig. 7 and Table 1 show the mechanical properties of air-dried fibres. U-Alg/PLGA and G-
Alg/PLGA fibres showed typical alginate fibre structure behaviour (while undergoing stress) 
by displaying an extra elongation before breaking completely (highlighted with the light grey 
dashed box in Fig. 7).41 G-Alg/PLGA fibres exhibit a lower mechanical strength compared 
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with U-Alg/PLGA fibres, which might be related to the non-uniform gradient distribution of 
the microspheres along the G-Alg/PLGA fibres. 
 
Protein release study 
Firstly, the FITC-BSA release profiles of the protein-loaded PLGA microspheres and Alg 
fibres were assessed to investigate the effect of both PLGA and alginate encapsulation on 
protein release. FITC-BSA-loaded PLGA microspheres showed a continued release for more 
than 35 days, with ~55% of the loaded protein being released within the observed period (Fig. 
8a). In vitro degradation study was undertaken by monitoring mass loss of the microspheres at 
various time intervals. Significant weight loss was noted only after two weeks’ incubation 
(~3% at week 2, ~12% at week 3, and ~23% at week 5). This result is consistent with those 
previously reported,42 and suggested that the protein release kinetics of the PLGA microspheres 
was predominantly diffusion-controlled in the first two weeks of release study, after which 
polymer degradation played an increasing role in modulating the release profile of the 
microspheres. By contrast, FITC-BSA directly encapsulated into Alg fibres shows a rapid 
release, with ≥ ~44% released at day 1 and ~70% at day 5. The 2nd week saw only ~1% protein 
being released from day 7 to day 10, after which no more released protein could be detected. 
 
The FITC-BSA release profile of U-Alg/PLGA and G-Alg/PLGA fibres are also presented in 
Fig. 8a. Both U-Alg/PLGA and G-Alg/PLGA fibres were designed to contain 20 wt% of 
protein-loaded PLGA microspheres and the practical protein loadings in U-Alg/PLGA and G-
Alg/PLGA fibres are reported in Table 2. Both fibres showed similar release profiles, with 
much reduced initial burst release at day 1 (~6% for both fibres). The amount of protein 
released by day 5 is ~23% of the total loading, after which a progressive reduction in the 
amount of protein released is noted. The cumulative amount of protein released is ~28% of the 
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total loading by day 15, and ~32% of the total loading by day 35 following a further reduction 
in the protein release rate after day 15. 
 
It is shown in Fig. 8a that the initial amounts of protein released from both fibres (≤ day 5) are 
close to that from the FITC-BSA-loaded PLGA microspheres alone. This, however, may be 
due to the premature release of protein from the microspheres prior to the solidification of 
fibres. To support this, we have assessed the amount of premature protein release, which 
revealed that ~6.1±4.2% of loaded protein was released into the spinning dope prior to the fibre 
formation. As shown in Fig. 8a, the protein release from U-Alg/PLGA or G-Alg/PLGA fibres 
after day 5 become much slower than the FITC-BSA-loaded PLGA microspheres or the FITC-
BSA-loaded Alg fibres alone. Fig. 8b provides a closer view of the protein release profiles from 
these two fibres at a later stage following day 5. Rather than reaching a plateau after 15 days, 
both fibres exhibit a further reduced, progressive release for more than 35 days.  This supports 
the view that incorporation of FITC-BSA loaded microspheres into an Alg fibrous matrix 
facilitates realisation of a more extended protein release profile. This is probably due to limited 
interactions between the encapsulated spheres and surrounding release medium and 
consequently reduced degradation kinetics as a result of alginate encapsulation. 
 
Similar studies by others provide some insight into the protein release profiles observed with 
U-Alg/PLGA and G/Alg/PLGA fibres.  Alsmadi et al.21 developed a nerve growth factor (NGF) 
loaded gradient structure within agarose microchannels. The structure was shown in vitro to be 
able to direct sensory axonal growth along NGF gradients. However, in terms of NGF release, 
the structure showed a large burst release at day 1 and completion of release by day 7. Johnson 
et al.43 developed 3D-printed nerve pathways to deliver NGF and glial cell line-derived 
neurotrophic factor in a gradient fashion. The bioactive molecules were directly loaded in a 
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modified gelatin hydrogel matrix. Completion of protein release was achieved in 21 days. 
Compared with the findings reported by Alsmadi and Johnson, incorporation of protein-loaded 
PLGA microspheres into an Alg fibrous matrix in a uniform or gradient manner results in much 
sustained release suitable for longer term release applications. 
 
We also studied the release profile of the two half sections of G-Alg/PLGA fibre (low protein-
loading end and high protein-loading end, as specified in Fig. 5b). The low protein-loading end 
has a practical microspheres loading of  ~ 28.6% of the total mass, and the high protein-loading 
end has a practical microspheres loading of ~ 69.2% of the total mass. As shown in Fig. 8d, 
like G-Alg/PLGA fibre, both the low protein-loading end and the high protein-loading end 
showed an initial slight burst release followed by a continuous release until day 10. Their 
release rates then became much slower until the end of the observation period (35 days). The 
high protein-loading end demonstrated a faster release rate, during the first 10 days, than the 
low protein-loading end. It seems that with increased concentration of microspheres, the Alg 
component in the resultant fibres is reduced, presenting, to a lesser degree, a diffusion barrier 
to the protein release. This suggests that the concentration of protein along the fibres can be 
spatiotemporally regulated by modulating the gradient distribution of protein-loaded 
microspheres within the structure.   
 
There are some other delivery configurations reported in recent years, which are capable of 
providing guidance (directing) platforms. For instance, Ostrovidov et al.22 used a microfluidic 
gradient generator to develop a microengineered hydrogel with a concentration gradient of 
okadaic acid for high-throughput analysis of drug-cell interactions. The drug was released from 
the hydrogel in a gradient manner and resulted in a gradient of cell viability. Although most of 
the gradient platforms reported to date could successfully deliver factors of interest in a specific 
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direction, they required complicated fabrication processes for achieving the gradient 
structure.21, 23 In addition, they displayed a rapid release profile with completion of release over 
a short period of few days.21,22,41-45 In contrast, the two-phase Alg fibre structure containing 
FITC-BSA-loaded PLGA microspheres presented here allows construction of a protein 
concentration gradient and delivery over a sustained period, which cannot be achieved with 
PLGA microspheres or Alg fibre alone.  
 
Conclusions 
In this study, we present a technique for fabrication of a two-phase Alg/PLGA fibre protein 
delivery system. FITC-BSA (a model protein) is encapsulated in PLGA microspheres and then 
incorporated into an Alg fibre structure via a custom-designed programmable wet-spinning 
method. The process demonstrates reliable production of Alg fibre with controlled presentation 
of the embedded protein. In particular, the system has demonstrated the capability to facilitate 
fibres that contained a defined microsphere concentration gradient that could be readily 
varied/tailored according to specific release requirements for the protein species in question. 
These fibres showed a more sustained release profile of protein than the protein-loaded PLGA 
microspheres or Alg fibres alone. The concentration gradient aspect of the two-phase 
Alg/PLGA fibre system presented here provides the possibility of guided chemotaxis by 
gradual presentation of cytokines or other growth factors in a spatially directional manner along 
a fibre. This has exciting potential for the applications in the promotion and direction of guided 
tissue regeneration in “linear” systems such as muscle and nerve. En route to this, further 
studies are required, such as incorporation of growth factor(s) of interest and optimization of 
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Fig. 1 (a) Schematic of the novel programmable wet-spinning technology. The extrusion rates 
of Alg spinning dope (in syringe A) and Alg/PLGA spinning dope (in syringe B) are adjusted 
using a CM Printing System-LinuxCNC via a home-designed coded software. The two 
spinning dopes were mixed in a mixing tube C to form the final spinning dope. Then the final 
dope was extruded through a needle to form a fibrous structure. (b) A closer view of the mixing 
tube C, where a small flexible blender was inserted to facilitate the mixing of the two spinning 
dopes. (c) Schematic illustration of U-Alg/PLGA and G-Alg/PLGA fibres produced using the 
above procedure.  
 
Fig. 2 (a) LVSEM image of the freeze-dried FITC-BSA-loaded PLGA microspheres, (b) laser 
confocal scanning microscopy image of the FITC-BSA-loaded PLGA microspheres dispersed 
in Alg spinning dope, and (c) size distribution of the as-prepared protein-loaded PLGA 
microspheres.  
 
Fig. 3 (a) Viscosity and (b) shear stress of Alg and Alg/PLGA spinning dopes. 
 
Fig. 2  Images of the as-spun U-Alg/PLGA. (a) is the optical image (depth of focus = 240 µm), 
and (b) is LVSEM image. Scale bars = 500 µm. 
 
Fig. 5 (a) The longitudinal LVSEM image of high protein-loading end of G-Alg/PLGA fibre. 
(b) Schematic and (c) optical image of G-Alg/PLGA fibre. (i)-(v) are the cross-sectional 
LVSEM images, samples taken at five different points as specified in (c) from low protein-
loading end i to high protein-loading end v of G-Alg/PLGA. (iv-a) is a higher magnification 
LVSEM image of iv. (d) is the longitudinal laser confocal scanning microscopy image of a 
representative G-Alg/PLGA fibre. (d-a), (d-b), (d-b) and (d-d) are closer views of the four 
different points as specified along the G-Alg/PLGA fibre.  
 
Fig. 6 FT-IR spectra of Alg, U-Alg/PLGA and G-Alg/PLGA fibres and FITC-BSA-loaded 
PLGA microspheres. 
 
Fig. 3 Stress-strain curves of U-Alg/PLGA and G-Alg/PLGA fibres. The dashed box highlights 
the extra elongation before the complete breakage of the fibres while undergoing stress. 
 
Fig. 8 (a) A comparison of the release profile from PLGA microspheres, Alg fibre, U-
Alg/PLGA and G-Alg/PLGA fibres. (b) A closer view of the FITC-BSA release profile of U-
Alg/PLGA and G-Alg/PLGA fibres from day 5 to day 35. (c) A comparison of the release 
profile from G-Alg/PLGA fibre, the low protein-loading end of the G-Alg/PLGA fibre and the 
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Herein we present a simple approach for fabrication of alginate fibers with programmable 
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